Itai Kela is a scientist and strategist leading external innovation outreach at Novo Nordisk, focusing on cardiometabolic diseases, oncology, and immunology. With postdoctoral training from Stanford and a PhD from Weizmann Institute, he specializes in building strategic partnerships to translate early science into transformative therapies. Colleagues note his exceptional ability to identify potential.
He co-founded a personalized medicine technology company for immunotherapy with a key scientific founder of Kite Pharma.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.